For the estimated 5 million people in the United States with atrial fibrillation, several treatment approaches can be utilized, each with a wide range of available pharmacological options. The AHA…
From disease basics to insightful analysis of market dynamics, Heart Failure | Disease Landscape & Forecast | G7 provides comprehensive disease coverage addressing critical aspects of the heart…
One of the most intriguing but administratively difficult trends in U.S. health insurers’ attempts to control the rising costs of prescription drugs is the use of outcomes-based contracting,…
The chronic heart failure therapy market is crowded and dominated by generics. In 2015 in the United States, the first new branded agents in more than 15 years entered that market. Using primary…
Despite advances in treatment, rates of mortality and hospitalization for worsening heart failure remain high among CHF patients, and development of therapies with improved efficacy is one of the…
Chronic heart failure patients are subject to high rates of mortality and morbidity and frequent readmissions to the hospital mean that chronic heart failure also represents a significant…
For the estimated 14.5 million diagnosed prevalent cases of asthma in the United States, there are multiple prescription therapies that are available for treating the associated symptoms. The…
For the estimated 4.9 million people in the United States who suffer from atrial fibrillation (AF), there are a number of different treatment approaches that can be utilized, each with a wide range…
Chronic heart failure (CHF) describes the long-term management of heart failure outside of the hospital setting. The disease progression of CHF is a gradual process that is heavily influenced by…
Hyperkalemia describes elevated levels of potassium in the blood. Although often asymptomatic, it can, if left untreated, cause cardiovascular problems, resulting in electrocardiogram (ECG)…
How Are Novel Therapies Differentiated from Current Treatment Options in This Highly Genericized Market? Acute heart failure (AHF) is one of the leading causes of hospitalization in the developed…
Pulmonary arterial hypertension (PAH) is a severe and debilitating disease with rapid progression and high rates of mortality. If left untreated, life expectancy is less than three years; even…
A Survey of Non-interventional Cardiologists and Managed Care Organization Pharmacy and Medical Directors Atherosclerosis refers to the thickening of arterial walls due to deposition of plaque; it…
For the estimated 4.6 million people in the United States who suffer from atrial fibrillation (AF), several treatment approaches and a wide range of pharmacological treatment options are available…
Heart failure describes a pathophysiological state in which the heart is unable to efficiently supply the body with oxygenated blood in order to meet the body’s metabolic demands. While acute…